Method AI

- 22/08/2025
- Series A
- $20,000,000
Working to deliver the next generation of technology-enabled surgery.
- Industry Medical Equipment Manufacturing
- Website https://www.methodsurgical.ai/
- LinkedIn https://www.linkedin.com/company/method-ai/
Related People
Doug TeanyCo Founder

Over the last decade, Doug has worked to shape the role that robotics will play in the future of medicine. He currently serves as CEO of Method AI, a company he co-founded with the Cleveland Clinic to improve outcomes for robotic-assisted surgery. Method AI aims to unlock the full value of surgical robotics through computer vision and automation, and they are starting where they can have the biggest impact for patients – surgical oncology.
Prior to Method AI, Doug served as COO for Corindus Vascular Robotics. In 2018, his team achieved the world’s first remote robotic interventional heart procedure – completed by an offsite physician located more than 20 miles from the patient. They followed that achievement with the first in-human robotic neurovascular intervention in 2019. The work of Doug and his team was featured in the 2020 documentary, Speed of Thought, a film following the first wave of 5G innovators in healthcare, public safety, and education.